Richard DiMarchi information

Richard D. DiMarchi (born December 5, 1952^[1]) is an American pharmaceutical chemist, academic, and businessman. He is the current chairman in biomolecular sciences and professor of chemistry at Indiana University. He is most notable for his work as a former vice president at Eli Lilly and Company.

He received his bachelor's degree from Florida Atlantic University in 1974, and his doctorate from Indiana University in 1979.^[2] He did his postdoctoral research at Rockefeller University under the mentorship of Nobel laureate Robert Bruce Merrifield.^[3]

DiMarchi recently developed a synthetic analog of the human version of the hormone glucagon. DiMarchi's glucagon analog possesses similar biological properties to natural glucagon. It dissolves easily and maintains its structural integrity over extended periods at room temperature.^[4]

DiMarchi left Eli Lilly in 2003 after working for 22 years, and has since founded six biotech companies based on the research he began there.^[5] He co-founded Ambrx along with Peter G. Schultz, that modifies therapeutic proteins to treat metabolic-related diseases, and later acquired by a Chinese consortium in 2015. In 2006, his lab at Indiana University spun off Marcadia Biotech, focusing on obesity and diabetes. It was sold to Roche in 2010, where DiMarchi worked on a part-time basis for three years. He co-founded Calibrium and MB2 in 2013 and 2015, respectively, both of which were eventually acquired by Novo Nordisk.^[3]^[5]

He is the Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry at Indiana University. He was inducted into the National Inventors Hall of Fame in 2014 for his role in the scientific advancements that led to the development of some of the first rDNA-derived medicines, including Humalog and Forteo.^[1] The following year, he was elected as member of the National Academy of Medicine.^[6] In 2016, he received the Alfred Burger Award in Medicinal Chemistry from American Chemical Society.^[3]

^ ^a ^b "Richard DiMarchi". National Inventors Hall of Fame. Retrieved January 26, 2024.
^ "Department of Chemistry at Indiana University – Richard D. DiMarchi". Indiana University Department of Chemistry. Retrieved November 24, 2006.
^ ^a ^b ^c McCoy, Michael (October 5, 2015). "C&EN Talks With Richard DiMarchi". Chemical & Engineering News.
^ "Richard DiMarchi is CICP's Innovator of the Year". Indiana University. Retrieved December 1, 2009.
^ ^a ^b Muller, Madison (January 26, 2024). "How a Lucky Break Fueled Eli Lilly's $600 Billion Weight-Loss Empire". Bloomberg Businessweek.
^ "DiMarchi Adds Another Honor". Inside Indiana Business. October 21, 2015.

[nihf-1] "Richard DiMarchi". National Inventors Hall of Fame. Retrieved January 26, 2024.

[2] "Department of Chemistry at Indiana University – Richard D. DiMarchi". Indiana University Department of Chemistry. Retrieved November 24, 2006.

[cen-3] McCoy, Michael (October 5, 2015). "C&EN Talks With Richard DiMarchi". Chemical & Engineering News.

[4] "Richard DiMarchi is CICP's Innovator of the Year". Indiana University. Retrieved December 1, 2009.

[bb-5] Muller, Madison (January 26, 2024). "How a Lucky Break Fueled Eli Lilly's $600 Billion Weight-Loss Empire". Bloomberg Businessweek.

[6] "DiMarchi Adds Another Honor". Inside Indiana Business. October 21, 2015.

Richard DiMarchi information

and 19 Related for: Richard DiMarchi information

Richard DiMarchi

Indiana University

List of National Inventors Hall of Fame inductees

Glucagon receptor agonist

List of members of the National Academy of Medicine

List of Florida Atlantic University people

Alexei Kharitonenkov

List of British Italians

List of American films of 2004

List of American films of 1983

Chery Tiggo 7

Giancarlo Giannini

List of Italian Canadians

Olivetti Valentine

Julian Jootaek Kim

List of musical acts from Western Australia

List of New York state senators

List of Ace Attorney characters

Frank Latimore